Inhibition of Renal Sodium–Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose

The objective of this study was to examine the effect of renal sodium–glucose cotransporter inhibition with empagliflozin on the fasting plasma glucose (FPG) concentration and β-cell function in subjects with impaired fasting glucose (IFG). Eight subjects with normal fasting glucose (NFG) and eight...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes
Main Authors: Abdul-Ghani, Muhammad, Al Jobori, Hussein, Daniele, Giuseppe, Adams, John, Cersosimo, Eugenio, Triplitt, Curtis, DeFronzo, Ralph A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2017
Assuntos:
Complications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7301341/
https://ncbi.nlm.nih.gov/pubmed/28611037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db17-0055
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados